Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hassel

Showing results (141-150 of 322) with videos related to

Pageof 33
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2025
Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [<sup>18</sup>F]FDG PET/CT studyChristos Sachpekidis, Devayani Machiraju, Dimitrios Stefanos Strauss, et al.
Cancer Medicine|December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanomaJessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.
Cancer Immunology, Immunotherapy : CII|June 7, 2018
Longitudinal studies of the <sup>18</sup>F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CTChristos Sachpekidis, Hoda Anwar, Julia K Winkler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Mareen Zielonka, Daniel Debatin, Arno Rütten, et al.
Journal of Clinical Microbiology|February 8, 2013
Varicella-like cutaneous toxoplasmosis in a patient with aplastic anemiaStefan Zimmermann, Eva Hadaschik, Alexander Dalpke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 18, 2019
Cerebral metastases of a dermatofibrosarcoma protuberansMareen Zielonka, Daniel Debatin, Arno Rütten, et al.
Melanoma Research|March 4, 2017
Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanomaHanna Blasig, Carolin Bender, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafuspJessica C Hassel, Carola Berking, Andrea Forschner, et al.
Scientific Reports|July 7, 2019
Macroangiopathy is a positive predictive factor for response to immunotherapyKaterina Deike-Hofmann, Lukas Gutzweiler, Julia Reuter, et al.
Cancers|October 21, 2020
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma PatientsMartin Salzmann, Karolina Benesova, Kristina Buder-Bakhaya, et al.
Pageof 33

Showing results (141-150 of 322) with videos related to

Sort By:
Pageof 33
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2025
Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [<sup>18</sup>F]FDG PET/CT studyChristos Sachpekidis, Devayani Machiraju, Dimitrios Stefanos Strauss, et al.
Cancer Medicine|December 22, 2017
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanomaJessica C Hassel, Kristina Buder-Bakhaya, Carolin Bender, et al.
Cancer Immunology, Immunotherapy : CII|June 7, 2018
Longitudinal studies of the <sup>18</sup>F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CTChristos Sachpekidis, Hoda Anwar, Julia K Winkler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Mareen Zielonka, Daniel Debatin, Arno Rütten, et al.
Journal of Clinical Microbiology|February 8, 2013
Varicella-like cutaneous toxoplasmosis in a patient with aplastic anemiaStefan Zimmermann, Eva Hadaschik, Alexander Dalpke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 18, 2019
Cerebral metastases of a dermatofibrosarcoma protuberansMareen Zielonka, Daniel Debatin, Arno Rütten, et al.
Melanoma Research|March 4, 2017
Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanomaHanna Blasig, Carolin Bender, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafuspJessica C Hassel, Carola Berking, Andrea Forschner, et al.
Scientific Reports|July 7, 2019
Macroangiopathy is a positive predictive factor for response to immunotherapyKaterina Deike-Hofmann, Lukas Gutzweiler, Julia Reuter, et al.
Cancers|October 21, 2020
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma PatientsMartin Salzmann, Karolina Benesova, Kristina Buder-Bakhaya, et al.
Pageof 33